Danny Haddad is a Nephrology physician affiliated with Jersey City Medical Center. OpenAlex indexes 13 publications with 277 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
7 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
56.9%Calcium channel blocker14.2%Amlodipine Besylate94%Nifedipine Er6%Part D<11 patientsBeta blocker11%Metoprolol Succinate42%Carvedilol34%Metoprolol Tartrate17%Labetalol Hcl8%Part D<11 patients+ 11 more classes in this area
Metabolism & gastrointestinal
20.4%SGLT2 inhibitor9.2%Farxiga73%Jardiance27%Part D<11 patientsVitamin D3 Analog7.8%Calcitriol68%Rayaldee32%Part D<11 patients+ 3 more classes in this area
Other
14.9%Drugs for treatment of hyperkalemia and hyperphosphatemia11%Lokelma48%Velphoro44%Lanthanum Carbonate8%Part D<11 patientsPhosphate Binder3.9%Sevelamer Carbonate100%Part D≥20 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- New Onset Anti-GBM Glomerulonephritis on a Background of IgA Nephropathy Post-SARS-CoV-2 Vaccination: A Double Hit Phenomenon?
Journal of the American Society of Nephrology
2022 - COVID-19 and the Kidneys, Implications and Outcomes.
PubMed
2021
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”